| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| INR-H52Ha | Human | Human Insulin R / CD220 (28-944) Protein, His Tag (SPR verified) |  |
|
|
Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) captured on CM5 chip via anti-His antibody, can bind Human Insulin with an affinity constant of 249 nM as determined in a SPR assay (Biacore T200) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human insulin (Hefei Tianmai Biotechnology) | Approved | Hefei Tianmai Biotechnology Development Co Ltd | Mainland China | Diabetes Mellitus | s:46:"Hefei Tianmai Biotechnology Development Co Ltd"; | 2018-04-28 | Diabetes Mellitus | Details | ||
| Insulin aspart biosimilar (Gan & Lee) | Approved | Gan & Lee Biotech | Mainland China | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:17:"Gan & Lee Biotech"; | 2020-06-05 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | ||
| Recombinant human insulin (SciGen) | Approved | Generex Biotechnology Corp | Recojet | India | Diabetes Mellitus | s:4:"null"; | 2004-12-01 | Diabetes Mellitus | Details | |
| Recombinant insulin glargine (Gan & Lee) | Approved | Gan & Lee Biotech | 长秀霖, Basalin | Mainland China | Diabetes Mellitus | s:25:"Gan & Lee Pharmaceuticals"; | 2005-05-10 | Diabetes Mellitus, Type 1; Diabetes Mellitus | Details | |
| Insulin biosimilar (Harvest Moon Pharmaceuticals) | Approved | Harvest Moon | N; | Diabetes Mellitus | Details | |||||
| Recombinant human insulin (Biocon) | Approved | Biocon | Insugen | India | Diabetes Mellitus | s:6:"Biocon"; | 2004-11-10 | Diabetes Mellitus | Details | |
| Insulin aspart biosimilar (Sanofi) | SAR-341402; SAR-Asp | Approved | Sanofi | EU | Diabetes Mellitus | s:14:"Sanofi-Aventis"; | 2020-06-25 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| Insulin biosimilar (Julphar) | Approved | Julphar (Gulf Pharmaceutical Industries) | Julphar Insulin R | Tunisia | Diabetes Mellitus | s:40:"Julphar (Gulf Pharmaceutical Industries)"; | 2013-10-01 | Diabetes Mellitus | Details | |
| Insulin glargine biosimilar (Biocon) | MYL-1501D | Approved | Mylan, Fujifilm Corp, Biocon Biopharmaceuticals | Basalog, Semglee | United States | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:25:"Mylan Pharmaceuticals Inc"; | 2009-01-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin biosimilar (Sedico) | Approved | Sedico | Insulin H bio R | Egypt | Diabetes Mellitus | s:6:"Sedico"; | 2013-02-01 | Diabetes Mellitus | Details | |
| Insulin human | HR-1799 | Approved | Sanofi Deutschland | Insulin Human Winthrop | United States | Diabetes Mellitus | s:22:"Baxter Healthcare Corp"; | 1997-02-21 | Diabetes Mellitus | Details |
| Recombinant human insulin (Tonghua Dongbao Pharmaceutical) | Approved | Tonghua Dongbao Pharmaceutical Co Ltd | 甘舒霖 | Mainland China | Diabetes Mellitus | s:37:"Tonghua Dongbao Pharmaceutical Co Ltd"; | 1998-01-01 | Diabetes Mellitus | Details | |
| Oral insulin (Generex Biotechnology) | Approved | Generex Biotechnology Corp | Oralin, Oralgen, Oral-lyn, Recosulin | Ecuador | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:4:"null"; | 2005-01-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | |
| Bacitracin | Approved | Pfizer Pharmaceuticals Ltd (China) | Bacterial Infections | s:34:"Pfizer Pharmaceuticals Ltd (China)"; | 1945-01-01 | Bacterial Infections | Details | |||
| Insul 30/70 biosimilar (Popular Pharmaceuticals) | Approved | Popular Pharmaceuticals | Insul 30-70 | N; | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational | Details | ||||
| Isophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals) | Approved | Popular Pharmaceuticals | Insulin N | Bangladesh | Diabetes Mellitus | s:23:"Popular Pharmaceuticals"; | 2013-01-01 | Diabetes Mellitus | Details | |
| Recombinant human insulin (United Laboratories International Holdings) | Approved | Zhuhai United Laboratories (Zhongshan) Co Ltd | 优思灵, Uslin | Mainland China | Diabetes Mellitus | s:53:"Zhongshan Branch of Zhuhai United Laboratories Co Ltd"; | 2009-11-25 | Diabetes Mellitus | Details | |
| Insulin lispro biosimilar (Sanofi) | SAR-342434 | Approved | Sanofi | Admelog | United States | Diabetes Mellitus, Type 2 | s:23:"Sanofi-Aventis U.S. Llc"; | 2017-07-18 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Isophane Protamine Recombinant Human Insulin (BIOTON） | Approved | Bioton | Mainland China | Diabetes Mellitus | s:6:"Bioton"; | 2013-03-29 | Diabetes Mellitus | Details | ||
| Human insulin biosimilar (Square Pharmaceuticals) | Approved | Square Pharmaceuticals | Ansulin | Bangladesh | Diabetes Mellitus | s:22:"Square Pharmaceuticals"; | 2013-01-01 | Diabetes Mellitus | Details | |
| Insulin glargine biosimilar (Wockhardt) | Approved | Wockhardt Bio Ag | Glaritus, Glaritus Cart, Glaritus DispoPen | India | Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:9:"Wockhardt"; | 2013-01-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech) | Approved | Shenzhen Kexing Biological Engineering Co Ltd | 苏泌啉恩 | Mainland China | Diabetes Mellitus | s:45:"Shenzhen Kexing Biological Engineering Co Ltd"; | 2003-02-24 | Diabetes Mellitus | Details | |
| Recombinant insulin (Horizon Pharma/Ibatech) | Approved | Savient Pharmaceuticals | Poland | Diabetes Mellitus, Type 1 | s:4:"null"; | 2002-07-01 | Diabetes Mellitus, Type 1 | Details | ||
| Insulin glargine biosimilar (Getz Pharma) | Approved | Getz Pharma | Basagine | N; | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | ||||
| Insulin biosimilar (Wockhardt) | Approved | Wockhardt | Wosulin, Wosulin®-R, Wosulin Pen, Wosulin Pen Royale | India | Diabetes Mellitus, Type 1 | s:9:"Wockhardt"; | 2003-10-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus | Details | |
| Recombinant human insulin (Incepta) | Approved | Incepta Pharmaceuticals | Maxsulin | Bangladesh | Diabetes Mellitus | s:23:"Incepta Pharmaceuticals"; | 2012-01-01 | Diabetes Mellitus | Details | |
| Human insulin biosimilar (MJ Biopharm) | Approved | Mj Biopharm Pvt | Biosulin | Russian Federation | Diabetes Mellitus | s:15:"Mj Biopharm Pvt"; | 2005-12-01 | Diabetes Mellitus | Details | |
| Insulin glargine biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals | Bangladesh | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:23:"Incepta Pharmaceuticals"; | 2012-08-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | ||
| Rinsulin NPH (Geropharm) | Approved | Geropharm | Rinsulin NPH | Russian Federation | Diabetes Mellitus | s:9:"Geropharm"; | 2012-10-01 | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| Insulin biosimilar (Popular Pharmaceuticals) | Approved | Popular Pharmaceuticals | Insul R | Bangladesh | Diabetes Mellitus | s:23:"Popular Pharmaceuticals"; | 2013-01-01 | Diabetes Mellitus | Details | |
| Insulin lispro protamine biosimilar (Gan & Lee Pharmaceuticals) | Approved | Gan & Lee Biotech | 速秀霖25, Suxiulin25 | Mainland China | Diabetes Mellitus | s:25:"Gan & Lee Pharmaceuticals"; | 2014-05-09 | Diabetes Mellitus | Details | |
| Isophane Protamine Recombinant Human Insulin(Novo Nordisk) | Approved | Novo Nordisk (China)Pharmaceuticals Co Ltd | N; | Diabetes Mellitus | Details | |||||
| Insulin human(Organon France) | Approved | Organon France | EU | Diabetes Mellitus | s:14:"Organon France"; | 1999-11-03 | Diabetes Mellitus | Details | ||
| Insulin human (inhalation powder) | SAR-439065 | Approved | Mannkind Corporation | Afresa, Afrezza, Technosphere Insulin System | United States | Diabetes Mellitus, Type 2 | s:13:"Mannkind Corp"; | 2014-06-27 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| Isophane Insulin(Polish Society of Diabetology) | Approved | Polish Society of Diabetology | N; | Diabetes Mellitus | Details | |||||
| Recombinant human insulin (Shenzhen Kexing Biotech) | Approved | Shenzhen Kexing Biological Engineering Co Ltd | 苏泌啉, Su Bi Lin | Mainland China | Diabetes Mellitus | s:45:"Shenzhen Kexing Biological Engineering Co Ltd"; | 2002-06-10 | Diabetes Mellitus | Details | |
| Insulin glulisine | HMR-1964 | Approved | Sanofi | 艾倍得, Apidra | Mainland China | Diabetes Mellitus | s:31:"Sanofi-Aventis Deutschland Gmbh"; | 2004-04-16 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Recombinant lispro insulin biosimilar (Gan & Lee) | Approved | Gan & Lee Pharmaceuticals | Mainland China | Diabetes Mellitus | s:25:"Gan & Lee Pharmaceuticals"; | 2006-01-19 | Diabetes Mellitus | Details | ||
| Insulin detemir | NN-304 | Approved | Novo Nordisk A/S | 诺和平, Levemir | Japan | Diabetes Mellitus | s:16:"Novo Nordisk A/S"; | 2004-06-01 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin degludec/Liraglutide | NN-9068 | Approved | Novo Nordisk A/S | Xultophy, iDegLira | Japan | Diabetes Mellitus, Type 2 | s:16:"Novo Nordisk A/S"; | 2014-09-18 | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin lispro | LYSPRO; LY-900027; LY-275585; Lys-B28; Pro-B29 | Approved | Eli Lilly And Company | Humalog, 优泌乐, Eglucent, Liprolog, Liumjev | United States | Diabetes Mellitus | s:20:"Eli Lilly And Co Ltd"; | 1996-04-30 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin glargine biosimilar (LG Life Sciences) | Approved | Lg Life Sciences Ltd | Basugine | N; | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | ||||
| Insulin glargine biosimilar (Zhuhai United) | Approved | Zhuhai United Laboratories Co Ltd | Mainland China | Diabetes Mellitus | s:33:"Zhuhai United Laboratories Co Ltd"; | 2016-12-23 | Diabetes Mellitus | Details | ||
| Insulin glargine/Lixisenatide | HOE-901/AVE-0010 | Approved | Sanofi | Soliqua, Suliqua, iGlarLixi | EU | Diabetes Mellitus, Type 2 | s:14:"Sanofi-Aventis"; | 2016-11-21 | Diabetes Mellitus, Type 2 | Details |
| Recombinant Human Insulin (Wanbang Pharma) | Approved | Jiangsu Wanbang Biopharmaceuticals | Mainland China | Diabetes Mellitus | s:35:"Jiangsu Wanbang Biopharmaceuticals "; | 2003-08-29 | Diabetes Mellitus | Details | ||
| Insulin glargine | U-300; Gla-100; Gla-300; Hoe-901; Hoe-71GT; HOE901-U300 | Approved | Sanofi | 来得时, Lantus, Toujeo, Lantus XR, Optisulin | Japan | Diabetes Mellitus | s:6:"Sanofi"; | 2000-04-20 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia; Diabetes Mellitus | Details |
| Insulin glargine biosimilar (YiChang HEC ChangJiang Pharmaceutical) | Approved | Guangdong Dongyangguang Pharmaceutical Co Ltd | Mainland China | Diabetes Mellitus | s:44:"Yichang Hec Changjiang Pharmaceutical Co Ltd"; | 2020-06-05 | Diabetes Mellitus | Details | ||
| Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical) | Approved | Tonghua Dongbao Pharmaceutical Co Ltd | 长舒霖 | Mainland China | Diabetes Mellitus | s:37:"Tonghua Dongbao Pharmaceutical Co Ltd"; | 2019-12-06 | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| Insulin degludec/Insulin aspart | NN-1045; NN-5401; NN-1250/Insulin aspart | Approved | Novo Nordisk A/S | 诺和佳, Ryzodeg | Mainland China | Diabetes Mellitus | s:16:"Novo Nordisk A/S"; | 2012-12-25 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin aspart | NN-1218; INA-X14; Insulin X14 | Approved | Novo Nordisk A/S | Novolog, NovoRapid, NovoLog FlexPen, NovoMix, Fiasp, 诺和锐, NovoRapid/NovoLog | Japan | Diabetes Mellitus | s:16:"Novo Nordisk A/S"; | 1999-09-07 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Ceritinib | LDK-378; NVP-LDK378; NVP-LDK378-NX | Approved | Novartis Pharma Ag | 赞可达, Zykadia | Mainland China | Carcinoma, Non-Small-Cell Lung | s:22:"Novartis Europharm Ltd"; | 2014-04-29 | Stomach Neoplasms; Glioblastoma; Adenocarcinoma of Lung; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Hepatic Insufficiency; Lymphoma, Large-Cell, Anaplastic; Carcinoma, Squamous Cell; Granuloma, Plasma Cell; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma | Details |
| Insulin degludec | NN-1250; Insulin-454 | Approved | Novo Nordisk A/S | 诺和达, Tresiba | Mainland China | Diabetes Mellitus, Type 2 | s:16:"Novo Nordisk A/S"; | 2012-09-28 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin glargine biosimilar (Lilly/Boehringer Ingelheim) | LY-2963016; LY2963016-U-100; LY2963016-U-200 | Approved | Boehringer Ingelheim Gmbh, Eli Lilly And Company | Abasria, Basaglar, Abasaglar | Japan | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | s:21:"Eli Lilly And Company"; | 2014-09-09 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin human (rDNA origin, Lilly) | S-3300; U-500R; LY-041001 | Approved | Eli Lilly And Company | 优泌林, Humulin, Humulin R, Humulin R Pen, Humulin R Kwikpen | Japan | Diabetes Mellitus | s:21:"Eli Lilly And Company"; | 1982-10-28 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin human (rDNA origin, Novo Nordisk) | NN-729 | Approved | Novo Nordisk A/S | Mixtard, Novolin, Actraphane, Insulatard | Japan | Diabetes Mellitus | s:16:"Novo Nordisk A/S"; | 1983-08-30 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Pulmonary Disease, Chronic Obstructive; Diabetes Mellitus | Details |
| Isophane Insulin | Approved | Jiangsu Wanbang Biopharmaceuticals | 万苏林 | Mainland China | Diabetes Mellitus | s:35:"Jiangsu Wanbang Biopharmaceuticals "; | 1997-01-01 | Diabetes Mellitus | Details | |
| Rosinsulin | Approved | Medsintez | N; | Diabetes Mellitus | Details | |||||
| Isophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology) | Approved | Hefei Tianmai Biotechnology Development Co Ltd | Mainland China | Diabetes Mellitus | s:46:"Hefei Tianmai Biotechnology Development Co Ltd"; | 2019-09-05 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Recombinant insulin aspart biosimilar (Biogenomics) | Phase 3 Clinical | Biogenomics | Diabetes Mellitus, Type 2 | Details | |
| 重组赖精胰岛素（合肥天麦） | Phase 3 Clinical | Hefei Tianmai Biotechnology Development Co Ltd | Diabetes Mellitus | Details | |
| Alirinetide | GM-6; GM-600; GM-602; GM-603; GM-604; GM-605; GM-606; GM-607; GM-608; GM-609 | Phase 2 Clinical | Genervon Biopharmaceuticals Llc | Stroke; Parkinson Disease; Amyotrophic Lateral Sclerosis | Details |
| Isophane Protamine Recombinant Human Insulin (Hec Pharm Co) | Phase 1 Clinical | Hec Pharm Co Ltd | Diabetes Mellitus | Details | |
| Insulin lispro/Insulin glargine | Phase 2 Clinical | Adocia | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details | |
| Insulin biosimilar (Valin Technologies) | Van-101 | Phase 3 Clinical | Valin Technologies | Diabetes Mellitus | Details |
| Insulin glargine biosimilar (Geropharm) | Phase 3 Clinical | Geropharm | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| CB-4211 | CB-4211 | Phase 1 Clinical | Cohbar | Non-alcoholic Fatty Liver Disease; Obesity | Details |
| Insulin Aspart 30 (Liaoning Bo'Ao Bio-Pharmaceutical) | Liaoning Bo'Ao Bio-Pharmaceutical Co Ltd | Details | |||
| AKP-11 | AKP-11 | Phase 2 Clinical | Akaal Pharma | Psoriasis | Details |
| Insulin detemir biosimilar (Tonghua Dongbao Pharmaceutical) | Phase 1 Clinical | Tonghua Dongbao Biotechnology Co Ltd | Diabetes Mellitus | Details | |
| Fast-acting human insulin (Adocia) | Hinsbet-U500; BioChaperone-222 | Phase 2 Clinical | Adocia | Diabetes Mellitus, Type 1 | Details |
| Dulaglutide/Basal insulin Fc | Phase 1 Clinical | Eli Lilly And Company | Diabetes Mellitus | Details | |
| Insulin glargine biosimilar (Valin Technologies) | Phase 1 Clinical | Valin Technologies | Diabetes Mellitus | Details | |
| Oral insulin (Purede) | Clinical | Puredel | Diabetes Mellitus | Details | |
| Pegylated recombinant human insulin (Chongqing Fujin Biomedical) | CA001 | Phase 1 Clinical | Chongqing Fujin Biological Medicine Co Ltd | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin aspart (Jilin Jinsheng) | Phase 1 Clinical | Jilin Jinsheng Pharmaceutical Co Ltd | Diabetes Mellitus | Details | |
| Recombinant human insulin (Eastgate Biotech) | EGP-1214 | Clinical | Eastgate Biotech | Prediabetic State; Diabetes Mellitus, Type 2 | Details |
| Insulin lispro (Diasome Pharmaceuticals) | Phase 2 Clinical | Diasome Pharmaceuticals | Diabetes Mellitus, Type 1 | Details | |
| Basal insulin Fc (Eli Lilly) | Phase 1 Clinical | Eli Lilly And Company | Diabetes Mellitus | Details | |
| Insulin biosimilar (University of Montreal Health Centre) | Phase 1 Clinical | University Of Montreal Health Centre | Glaucoma | Details | |
| Insulin aspart biosimilar (Biocon/Mylan) | MYL-1601D | Phase 3 Clinical | Biocon | Diabetes Mellitus, Type 1 | Details |
| Insulin aspart biosimilar (Geropharm) | GP-40071; GP-40081 | Phase 3 Clinical | Geropharm | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin mouth rinse (EastGate Biotech) | Phase 3 Clinical | Genome Pharmaceuticals, Eastgate Biotech | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Alzheimer Disease | Details | |
| XOMA-358 | XOMA-247; RZ358; RZ-358; XPA.15.247; XOMA-358 | Phase 2 Clinical | Xoma | Congenital Hyperinsulinism; Hypoglycemia; Hyperinsulinism | Details |
| Insulin glargine biosimilar (Wanbang Biochemical) | Phase 3 Clinical | Jiangsu Wanbang Biopharmaceuticals | Diabetes Mellitus, Type 2 | Details | |
| Insulin Aspart 30 (Yichang Hec Changjiang Pharmaceutical) | Yichang Hec Changjiang Pharmaceutical Co Ltd | Details | |||
| Long-acting basal insulin analogue | LAI-287; NN-1436; NN-1956; OI-287GT; 148-0287-A; Insulin-287; NNC0148-0287 C; NNC-0148-0000-0287; Long-acting-insulin-287; Long-acting basal insulin analogue | Phase 3 Clinical | Novo Nordisk A/S | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| PE-0139 | PE-0139 | Phase 2 Clinical | Phasebio | Diabetes Mellitus, Type 2 | Details |
| NP-01 (Medesis Pharma SA) | NP01 | Phase 1 Clinical | Medesis Pharma Sa | Diabetes Mellitus, Type 2 | Details |
| Insulin glargine (Hefei Tianmai) | Phase 1 Clinical | Hefei Tianmai Biotechnology Development Co Ltd | Diabetes Mellitus | Details | |
| Insulin oral (Diabetology) | DTY-001 | Phase 2 Clinical | Diabetology Ltd | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details |
| Insulin biosimilars (Bioton) | Clinical | Bioton | Diabetes Mellitus | Details | |
| Recombinant insulin glargine (Chongqing Fujin Biological Medicine) | Phase 3 Clinical | Chongqing Fujin Biological Medicine Co Ltd | Diabetes Mellitus, Type 2 | Details | |
| Recombinant human insulin biosimilar (Rechon Life Sciences) | Phase 3 Clinical | Rechon Life Science | Diabetes Mellitus, Type 1 | Details | |
| Pramlintide/Insulin | ADO-09 | Phase 2 Clinical | Adocia | Diabetes Mellitus, Type 1 | Details |
| Oral insulin-338-C10 | LAI-338; NN-1438; NN-1953; OI-338GT; NNC0123-0338; Insulin-338-GIPET-I; Oral insulin 338 C10 | Phase 2 Clinical | Merrion Pharmaceuticals, Novo Nordisk A/S | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Recombinant human insulin (Nutrinia) | NTRA-9620 | Phase 3 Clinical | Nutrinia | Diabetes Mellitus, Type 2; Short Bowel Syndrome | Details |
| DM199 | DM-99; DM-199 | Phase 2 Clinical | Diamedica | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Kidney Diseases; Stroke; Alzheimer Disease; Renal Insufficiency, Chronic; Diabetes Mellitus | Details |
| Insulin (Coremed) | Phase 1 Clinical | Coremed | Diabetes Mellitus | Details | |
| Recombinant human insulin (Zhejiang Hisun Pharmaceutical) | Zhejiang Hisun Pharmaceutical Co Ltd | Details | |||
| Intranasal insulin (Johns Hopkins University) | Phase 2 Clinical | Johns Hopkins University | Neurocognitive Disorders; Multiple Sclerosis | Details | |
| Insulin Aspart (Beijing Sl Pharmaceutical) | Phase 3 Clinical | Beijing Sl Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details | |
| Recombinant human insulin(30/70) (Zhejiang Hisun Pharmaceutical) | Phase 3 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details | |
| Mixed Protamine Zinc Recombinant Insulin Lispro Injection(25R)（Tonghua Dongbao） | Phase 3 Clinical | Tonghua Dongbao Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details | |
| HM-12460A | HM-12470; HM-12470A; SAR-440067 | Phase 1 Clinical | Hanmi Pharmaceutical Co Ltd | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details |
| Insulins (Halozyme) | Aspart-PH20; Lispro-PH20; Insulin-PH20; rHuPH20/insulin; Analog insulin-PH20 | Phase 2 Clinical | Halozyme Therapeutics Inc | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dermatitis, Allergic Contact; Diabetes Mellitus | Details |
| Ultra fast-acting insulin (Adocia) | BC-222-Insulin-Lispro; BC-106-Insulin-Lispro; THDB-0206; THDB0206 | Phase 3 Clinical | Adocia | Diabetes Mellitus, Type 1; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Insulin lispro biosimilar (Wanbang Biopharma) | Phase 3 Clinical | Jiangsu Wanbang Biopharmaceuticals | Diabetes Mellitus | Details | |
| Insulin Glargine (Zhejiang Hisun Pharmaceutical) | HS004 | Phase 3 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Diabetes Mellitus | Details |
| INS-068 | INS-068 | Phase 2 Clinical | Chengdu Suncadia Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd, Jiangsu Hengrui Medicine Co Ltd | Diabetes Mellitus, Type 2 | Details |
| AB-101 | AB-101 | Phase 2 Clinical | Rezolute, Ipr Pharmaceuticals | Diabetes Mellitus, Type 1; Breast Neoplasms; Sexual Dysfunction, Physiological; Lymphoma, Non-Hodgkin; Mental Disorders | Details |
| Insulin (Oramed Pharmaceuticals) | ORMD-0801 | Phase 3 Clinical | Oramed Pharmaceuticals | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus | Details |
| Insulin icodec | 148-0287-A; Insulin-287; LAI-287; Long-acting basal insulin analogue; Long-acting-insulin-287; NN-1436; NN-1956; NNC-0148-0000-0287; NNC0148-0287 C; OI-287GT | Phase 3 Clinical | Novo Nordisk A/S | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
| Isophane Protamine Recombinant Human Insulin (Jilin Huisheng Biological ) | Phase 3 Clinical | Jilin Huisheng Biological Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details | |
| Semaglutide/Insulin 287 | NNC0148-0287sema | Phase 1 Clinical | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | Details |
This web search service is supported by Google Inc.
A-Z